Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alicia Martín Roldán"'
Autor:
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Carolina Alarcón-Payer, Miguel Ángel Rodríguez-Gil, Jaime Eduardo Poquet-Jornet, José Manuel Puerta Puerta, Alberto Jiménez Morales
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 55 (2023)
Chronic lymphocytic leukemia is a lymphoproliferative disorder marked by the expansion of monoclonal, mature CD5+CD23+ B cells in peripheral blood, secondary lymphoid tissues, and bone marrow. The disease exhibits significant heterogeneity, with nume
Externí odkaz:
https://doaj.org/article/9ab1ed293fd0427ea1d38c761853b905
Autor:
Alicia Martín Roldán, María Del Mar Sánchez Suárez, Carolina Alarcón-Payer, Alberto Jiménez Morales, José Manuel Puerta Puerta
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1363 (2023)
The therapeutic approach to chronic myeloid leukaemia (CML) has changed in recent years. As a result, a high percentage of current patients in the chronic phase of the disease almost have an average life expectancy. Treatment also aims to achieve a s
Externí odkaz:
https://doaj.org/article/58932818415e4015a784dd1712ac3874
Autor:
María Del Mar Sánchez Suárez, Alicia Martín Roldán, Maria Rosa Cantudo Cuenca, Alberto Jiménez Morales
Purpose The ageing population with multiple sclerosis could be related to potentially inappropriate medication prescriptions, drug-drug interactions and therapeutic non-adherence. The PIMDINAC criteria aim to jointly analyse these problems. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e7adc67b3b44efe5f83dc566baf6a86
https://doi.org/10.21203/rs.3.rs-2609097/v1
https://doi.org/10.21203/rs.3.rs-2609097/v1
Autor:
Carolina Alarcón-Payer, María Del Mar Sánchez Suárez, Alicia Martín Roldán, José Manuel Puerta Puerta, Alberto Jiménez Morales
Publikováno v:
Journal of Personalized Medicine. 12:1607
Most malignant hematological diseases are generally a consequence of acquired mutations or rearrangements in cell replication processes. Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease that results from acquired gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995189969312c6e766b4be527e75d824
https://doi.org/10.3390/jpm12101607
https://doi.org/10.3390/jpm12101607
Autor:
Sánchez Suárez MM, Martín Roldán A; Alicia Martín Roldán, Hospital Universitario Virgen de las Nieves. Postal address: Avenida de las Fuerzas Armadas, 2, 18014, Granada, Spain. aliciamartinroldan@gmail.com., Cantudo Cuenca MR
Publikováno v:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Jun; Vol. 37 (3), pp. 283-284. Date of Electronic Publication: 2024 Apr 19.